Product Information
METFORMIN HCL ER 750 MG TABLET is a generic product labeled by TAGI Pharma Inc., priced at $0.0687 per EA under NDC 51224010750. Its NADAC has been published 431 times since Aug 17, 2016.
Strength
750 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224010750
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078321On Market Since
4/17/2008
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 431 times since Aug 17, 2016, and over the history we have for it it has declined 36.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0687 per EA |
|---|---|
| All-time high | $0.1103 (Oct 12, 2016) |
| All-time low | $0.0546 (Jul 17, 2024) |
| Median price | $0.0706 |
| Average price | $0.0737 |
| Largest weekly change | +26.5% (Dec 23, 2020) |
| Weeks tracked | 431 |
| Tracking since | Aug 17, 2016 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by TAGI Pharma Inc., is $0.0687 per EA (NDC 51224010750), effective Nov 13, 2024.
How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 36.9%. It has been tracked across 431 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?
Since Aug 17, 2016, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0546 (Jul 17, 2024) to a high of $0.1103 (Oct 12, 2016), with a median of $0.0706 per EA.
Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?
Yes. 10 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METFORMIN HCL ER 750 MG TABLET, is $0.0546 per EA — about 20% below METFORMIN HCL ER 750 MG TABLET.
Who manufactures METFORMIN HCL ER 750 MG TABLET?
METFORMIN HCL ER 750 MG TABLET (NDC 51224010750) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification